A NOVEL COCULTURE MODEL FOR BENIGN PROSTATIC HYPERPLASIA EXPRESSING BOTH ISOFORMS OF 5-ALPHA-REDUCTASE

Citation
Cw. Bayne et al., A NOVEL COCULTURE MODEL FOR BENIGN PROSTATIC HYPERPLASIA EXPRESSING BOTH ISOFORMS OF 5-ALPHA-REDUCTASE, The Journal of clinical endocrinology and metabolism, 83(1), 1998, pp. 206-213
Citations number
31
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
0021972X
Volume
83
Issue
1
Year of publication
1998
Pages
206 - 213
Database
ISI
SICI code
0021-972X(1998)83:1<206:ANCMFB>2.0.ZU;2-I
Abstract
We have developed a coculture system for primary fibroblast and epithe lial cells derived from benign prostatic hyperplasia (BPH) that retain ed many of the characteristics of the intact human prostate. In contra st to separately cultured prostate fibroblast and epithelial cells, co cultures of fibroblasts and epithelial cells maintained messenger ribo nucleic acid expression and functional activity for both isoenzymes of 5 alpha-reductase (type I and type II) as well as maintained expressi on of androgen receptors and prostate-specific antigen. Furthermore, l evels of prostate-specific antigen secreted by cocultured epithelial c ells were increased by treatment with androgens, mimicking the situati on in the human gland. This contrasted with conventionally cultured fi broblasts or epithelial cells, which failed to express 5 alpha-reducta se type II and rapidly lost expression of androgen receptors and andro gen sensitivity upon being placed into culture. Electron microscopy de monstrated intracellular structures indicative of the differentiated s tate of the cocultured cell types, including round nuclei, tonofibrils , and microvilli in epithelial cells and elongated nuclei; large amoun ts of Golgi and cilia; along with immature collagen fibers in fibrobla sts. The present study demonstrates that the coculture model reflects more closely the in vivo system for human BPH and is thus a far more s uitable model for investigating the molecular and cellular events that underlie BPH than current in vitro systems.